Flexion Therapeutics
Data Breaches, Cyber Attacks and Security Report

https://flexiontherapeutics.com  ᛫ 
Last updated December 14, 2019

About Flexion Therapeutics

Company Overview

Flexion Therapeutics is an American pharmaceutical company based in Burlington, Massachusetts that is developing reformulated sustained release versions of existing drugs that are intended to be injected into the joint to treat osteoarthritis.It was founded around 2007 by two former Eli Lilly & Co. executives and went public in 2014.In November 2016 the FDA accepted Flexion's New Drug Application for FX006, a sustained-release formulation of triamcinolone acetonide (a corticosteroid), branded "Zilretta".

Valuation

$930,117,500

Employees

251

CEO

Location

Burlington, MA, United States.

Data Breaches and Security News

Flexion Therapeutics Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Flexion Therapeutics is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Flexion Therapeutics

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Flexion Therapeutics's security performance with other companies